Skip to content

Clinical trials

Granulomatosis with Polyangiitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Granulomatosis with Polyangiitis Clear all

104 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20021
20034
20042
20052
20061
20071
20083
20104
20115
20126
20134
20148
201510
20161
20171
20184
20195
20204
20212
20223
20232
20245
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Unknown status17
Recruiting14
Terminated11
Active, not recruiting5
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)12
Assistance Publique - Hôpitaux de Paris11
University of Pennsylvania11
University of South Florida7
Cambridge University Hospitals NHS Foundation Trust4
Charite University, Berlin, Germany2
Chiba University2
Hoffmann-La Roche2
InflaRx GmbH2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Granulomatosis with Polyangiitis104
Microscopic Polyangiitis62
Vasculitis41
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis36
Churg-Strauss Syndrome25
Polyarteritis Nodosa16
Takayasu Arteritis15
Giant Cell Arteritis14
Systemic Vasculitis10
IgA Vasculitis9

Trials

Showing 26 to 50 of 104. Each trial links to its page on Pharma Observatory.

4 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.